Updated 12:01 GMT, 12 Nov 2026 SPX 7,619.38 +1.31% NDX 28,374.25 +2.28% VIX 18.29 +4.57% GOLD 3,952.00 -1.21% CL 85.98 -0.64% BTC 72,804.81 -1.57%
NAS100 28,374 +2.28% S&P 7,619 +1.31% GOLD $3,952 −1.21% BTC $72,805 −1.57% VIX 18.29 +4.57% latest tape · as of 12:01 UTC
The Screen · Communication Services · Advertising Agencies

U-BX Technology Ltd

UBXG · NASDAQ · USD · Market cap $9M · 15 employees

U-BX Technology Ltd., together with its subsidiaries, focuses on providing value-added services using artificial intelligence-driven technology to businesses in the insurance industry in China.

Not yet scored
6.13 USD

Price as of 27 Jul 2026Daily close, not a live quoteLast reviewed 108 days ago

Screened 2026-07-27 · the tape above runs as of 12:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price6.13 USD at the 27 Jul 2026 close
  • Our regime readMarkup, as of 8 Nov 2026
  • Ethical screenNot yet scored
  • Last reviewed27 Jul 2026 (108 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: range not available (screen dated 2026-07-27).

Current read
Markup ?
Screened · screened 2026-07-27
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical screen not yet scored
Price6.13 USD
Ethical score70.0/100
Our investment reviews on this name
2026-08-15Read Markup5.03+21.9% to today ✓Distribution gives way to Markup after a 36% slide in 6 weeks
2026-07-02Read Distribution7.87-22.1% to today ✓First review on file: Distribution

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

U-BX Technology Ltd holds its Markup at $6.13. Consolidating, no directional conviction, held for 368 days.

As held on the ledger · 2026-07-27
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 368 days
Price at the screen$6.13
ValuationN/A trailing · N/A forward price to earnings
Values screenNot scored · score 70.0
Beta-5.52
The Workings

Five Screens, Shown in Full

This security has not been fully scored against the values screen yet.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

The Read, in Plain English

U-BX Technology clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.

Read as at 2026-11-11. It updates when the underlying figures move, and past reads are kept below.

2026-10-04

U-BX Technology clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.

2026-09-24

We do not yet have the financial statements needed to run the debt, cash, receivables and income screens for U-BX Technology, so it is not scored yet.

Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.

The Business, in Plain Words
The fundamentals · plain-English read
EPS, trailing-22.75
Revenue growth-32.6%revenue is shrinking
Profit margin-55.1%currently unprofitable
Return on equity-46.6%not currently earning a positive return on equity
FCF yield-80.69%
Current ratio20.55comfortably covers its short-term bills
Beta-5.52barely tracks the market's swings
Short interest, float0.04%
52-week range2.12 - 112.50
MoatNONE
Market cap$9M
Employees15

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to China and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

UBXG trades on NASDAQ (the company is based in China). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-04 Markup $6.13 +0.0% Entry 8

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 96%. Our forward projection puts the odds of a 10% gain over the next month near 20%.

2026-10-23 Markup $6.13 +0.0% Entry 7

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 96%. Our forward projection puts the odds of a 10% gain over the next month near 20%.

2026-10-02 Markup $6.13 +21.9% Entry 6

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 21.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 96%. Our forward projection puts the odds of a 10% gain over the next month near 20%.

2026-09-15 Markup $5.03 +0.0% Entry 5

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 96%. Our forward projection puts the odds of a 10% gain over the next month near 20%.

2026-08-15 Markup · changed $5.03 -36.1% Entry 4

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 36.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 96%. Our forward projection puts the odds of a 10% gain over the next month near 20%.

2026-07-18 Distribution $7.87 +0.0% Entry 3

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 96%. Our forward projection puts the odds of a 10% gain over the next month near 20%.

2026-07-03 Distribution $7.87 +0.0% Entry 2

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.

2026-07-02 Distribution $7.87 Entry 1

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Related Securities · Others in UBXG's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $7.55 -57.1% · $429 -57.1%
2 months $26.50 -87.8% · $122 -87.8%
3 months $45.25 -92.8% · $72 -92.8%
6 months $53.75 -94.0% · $60 -94.0%
1 year $84.25 -96.2% · $39 -96.2%
2 years $237.00 -98.6% · $14 -98.6%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever UBXG does next, these words stay.

U-BX Technology Ltd · UBXG · Markup · $6.13
Recorded 2026-07-27 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.